Healthcare -
Biotechnology - NASDAQ - US
$ 103.32
-3.21 %
$ 9.87 B
Market Cap
44.15
P/E
Price Target
Average
73.83%
Revenue Forecast
Estimate
53.54%
EBIT
Estimate
--127.47%
Net Income
Estimate
70.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sarepta Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SRPT of $180 , with forecasts ranging from
a
low of
$141 to a high of $205 .
SRPT Lowest Price Target
Wall Street Target
141 USD
36.47%
SRPT Average Price Target
Wall Street Target
180 USD
73.83%
SRPT Highest Price Target
Wall Street Target
205 USD
98.41%
REVENUE FORECAST
Revenue Forecast Chart SRPT
EBIT FORECAST
EBIT Forecast Chart SRPT
NET INCOME FORECAST
Net Income Chart SRPT